Fundz

Myosin Therapeutics raised over $3M in a seed round led by DeepWork Capital and others to advance its brain therapies for cancer and neurological disorders.

PRIVATEMar 05, 2025

Amount Raised

$3 Million

Round Type

Seed

JupiterHealthcareHealth Care

Investors

Florida Opportunity FundDeepWork CapitalThe Sontag Innovation FundMayo Clinic VenturesDynagrow CapitalMint12 Pharma

Description

Myosin Therapeutics has closed its second seed funding round, successfully raising more than $3 million. The funding will support the development of therapies targeting critical unmet medical needs in oncology and neuroscience, including treatments for glioblastoma and methamphetamine use disorder.

Quick answer

Myosin Therapeutics raised $3 Million in a Seed round, dated March 5, 2025. Investors: Florida Opportunity Fund, DeepWork Capital, The Sontag Innovation Fund, Mayo Clinic Ventures, Dynagrow Capital and Mint12 Pharma. Myosin Therapeutics is based in Jupiter, Florida, United States.

How much did Myosin Therapeutics raise?
Myosin Therapeutics raised $3 Million in a Seed round on March 5, 2025.
Who invested in Myosin Therapeutics?
Florida Opportunity Fund, DeepWork Capital, The Sontag Innovation Fund, Mayo Clinic Ventures, Dynagrow Capital and Mint12 Pharma are named as investors in this round.
What does Myosin Therapeutics do?
Myosin Therapeutics is a pioneering nanomotor platform company dedicated to improving health outcomes through novel pharmacotherapies targeting the myosin family of molecular motors.
Where is Myosin Therapeutics based and how big is it?
Myosin Therapeutics is based in Jupiter, Florida, United States. Fundz records about 8 employees.
Who are the decision-makers at Myosin Therapeutics?
Fundz holds 1 contact at Myosin Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Health Care around the same time

Companies in the same sectors as Myosin Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Hummingbird Healthcare raised $20M (Series B) on February 21, 2025.
  • Hummingbird Healthcare raised $19M on February 14, 2025.
  • Imagen Dental Partners raised $2.3M on April 17, 2025.
  • Flyte raised $137K (Seed) on April 15, 2025.
  • Shape Memory Medical raised $4.4M (Series C) on April 15, 2025.
  • Prescribe FIT raised $300K (Seed) on April 11, 2025.

Who to call at Myosin Therapeutics, and when

A new round usually means Myosin Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Myosin Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Myosin Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Myosin Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Myosin Therapeutics

Location

130 SCRIPPS WAY, 3B3

Jupiter, Florida, United States

About

Myosin Therapeutics is a pioneering nanomotor platform company dedicated to improving health outcomes through novel pharmacotherapies targeting the myosin family of molecular motors. As the first nMotor-driven oncology company, Myosin leverages its proprietary drug discovery system to develop a robust pipeline of therapeutics. This includes a groundbreaking treatment for Glioblastoma (GBM)—a critical unmet need affecting at least 10,000 patients annually in the U.S.—and a unique neurotherapeutic aimed at preventing relapse in METH use disorder, for which no FDA-approved medications currently exist. Beyond these, Myosin’s research into NMII-targeting pharmacotherapies holds promise across multiple areas, including cancer, substance use disorders, neural regeneration, and infectious diseases, driving forward both therapeutic innovation and scientific discovery.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Myosin Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Myosin Therapeutics's next move

See what Strategic adds

Myosin Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.